King Launches Embeda Analyst Blog
Posted by admin | Filed under Oxycontin Addictions
More info…
Earlier this week, King Pharmaceuticals, Inc. ( KG ) announced the launch of Embeda, which recently received U.S. Food and Drug Administration (FDA) approval for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Embeda, which is the first FDA-approved long-acting opioid designed to reduce drug liking and euphoria when tampered with by crushing or chewing, will be available in six dosage strengths. As per
Tags: oxicontin addiction
Leave a Reply
You must be logged in to post a comment.